249 related articles for article (PubMed ID: 32844230)
1. The microRNA target site landscape is a novel molecular feature associating alternative polyadenylation with immune evasion activity in breast cancer.
Kim S; Bai Y; Fan Z; Diergaarde B; Tseng GC; Park HJ
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32844230
[TBL] [Abstract][Full Text] [Related]
2. Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.
Chu Y; Elrod N; Wang C; Li L; Chen T; Routh A; Xia Z; Li W; Wagner EJ; Ji P
Oncogene; 2019 May; 38(21):4154-4168. PubMed ID: 30705404
[TBL] [Abstract][Full Text] [Related]
3. NUDT21 regulates 3'-UTR length and microRNA-mediated gene silencing in hepatocellular carcinoma.
Sun M; Ding J; Li D; Yang G; Cheng Z; Zhu Q
Cancer Lett; 2017 Dec; 410():158-168. PubMed ID: 28964783
[TBL] [Abstract][Full Text] [Related]
4. Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer.
Kim N; Chung W; Eum HH; Lee HO; Park WY
PLoS One; 2019; 14(5):e0217196. PubMed ID: 31100099
[TBL] [Abstract][Full Text] [Related]
5. NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
Tan S; Li H; Zhang W; Shao Y; Liu Y; Guan H; Wu J; Kang Y; Zhao J; Yu Q; Gu Y; Ding K; Zhang M; Qian W; Zhu Y; Cai H; Chen C; Lobie PE; Zhao X; Sun J; Zhu T
Oncogene; 2018 Aug; 37(35):4887-4900. PubMed ID: 29780166
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers.
Wang L; Lang GT; Xue MZ; Yang L; Chen L; Yao L; Li XG; Wang P; Hu X; Shao ZM
Theranostics; 2020; 10(23):10531-10547. PubMed ID: 32929364
[No Abstract] [Full Text] [Related]
7. Transforming growth factor β1 alters the 3'-UTR of mRNA to promote lung fibrosis.
Ko J; Mills T; Huang J; Chen NY; Mertens TCJ; Collum SD; Lee G; Xiang Y; Han L; Zhou Y; Lee CG; Elias JA; Jyothula SSK; Rajagopal K; Karmouty-Quintana H; Blackburn MR
J Biol Chem; 2019 Oct; 294(43):15781-15794. PubMed ID: 31488543
[TBL] [Abstract][Full Text] [Related]
8. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
[TBL] [Abstract][Full Text] [Related]
9. Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma.
Venkat S; Tisdale AA; Schwarz JR; Alahmari AA; Maurer HC; Olive KP; Eng KH; Feigin ME
Genome Res; 2020 Mar; 30(3):347-360. PubMed ID: 32029502
[TBL] [Abstract][Full Text] [Related]
10. The role of NUDT21 in microRNA-binging sites of EZH2 gene increases the of risk preeclampsia.
Lang X; Zhao W; Huang D; Liu W; Shen H; Xu L; Xu S; Huang Y; Cheng W
J Cell Mol Med; 2019 May; 23(5):3202-3213. PubMed ID: 30883033
[TBL] [Abstract][Full Text] [Related]
11. Recurrent tumor-specific regulation of alternative polyadenylation of cancer-related genes.
Xue Z; Warren RL; Gibb EA; MacMillan D; Wong J; Chiu R; Hammond SA; Yang C; Nip KM; Ennis CA; Hahn A; Reynolds S; Birol I
BMC Genomics; 2018 Jul; 19(1):536. PubMed ID: 30005633
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming of 3' untranslated regions of mRNAs by alternative polyadenylation in generation of pluripotent stem cells from different cell types.
Ji Z; Tian B
PLoS One; 2009 Dec; 4(12):e8419. PubMed ID: 20037631
[TBL] [Abstract][Full Text] [Related]
13. NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.
Xiong M; Chen L; Zhou L; Ding Y; Kazobinka G; Chen Z; Hou T
Theranostics; 2019; 9(24):7156-7167. PubMed ID: 31695759
[No Abstract] [Full Text] [Related]
14. NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC1.
Jonnakuti VS; Ji P; Gao Y; Lin A; Chu Y; Elrod N; Huang KL; Li W; Yalamanchili HK; Wagner EJ
J Neurooncol; 2023 Jul; 163(3):623-634. PubMed ID: 37389756
[TBL] [Abstract][Full Text] [Related]
15. Differential genome-wide profiling of tandem 3' UTRs among human breast cancer and normal cells by high-throughput sequencing.
Fu Y; Sun Y; Li Y; Li J; Rao X; Chen C; Xu A
Genome Res; 2011 May; 21(5):741-7. PubMed ID: 21474764
[TBL] [Abstract][Full Text] [Related]
16. Modulation of untranslated region alternative polyadenylation in glioma tumorigenesis.
Lan YL; Zhang J
Biomed Pharmacother; 2021 May; 137():111416. PubMed ID: 33761620
[TBL] [Abstract][Full Text] [Related]
17. Differential microRNA regulation correlates with alternative polyadenylation pattern between breast cancer and normal cells.
Liaw HH; Lin CC; Juan HF; Huang HC
PLoS One; 2013; 8(2):e56958. PubMed ID: 23437281
[TBL] [Abstract][Full Text] [Related]
18. Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types.
Xia Z; Donehower LA; Cooper TA; Neilson JR; Wheeler DA; Wagner EJ; Li W
Nat Commun; 2014 Nov; 5():5274. PubMed ID: 25409906
[TBL] [Abstract][Full Text] [Related]
19. Implications of polyadenylation in health and disease.
Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
[TBL] [Abstract][Full Text] [Related]
20. APA-Scan: detection and visualization of 3'-UTR alternative polyadenylation with RNA-seq and 3'-end-seq data.
Fahmi NA; Ahmed KT; Chang JW; Nassereddeen H; Fan D; Yong J; Zhang W
BMC Bioinformatics; 2022 Sep; 23(Suppl 3):396. PubMed ID: 36171568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
